Southern Asia: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Southern Asia

In 2021, after three years of growth, there was significant decline in the South Asian human and animal blood market, when its value decreased by -X% to $X. The market value increased at an average annual rate of +X% from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The level of consumption peaked at $X in 2020, and then reduced in the following year.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Southern Asia

In value terms, human and animal blood production dropped to $X in 2021 estimated in export price. The total output value increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2018 when the production volume increased by X%. The level of production peaked at $X in 2020, and then declined in the following year.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in Southern Asia

In 2021, human and animal blood exports in Southern Asia soared to X tons, picking up by X% against the previous year's figure. Overall, exports showed a significant expansion. The most prominent rate of growth was recorded in 2020 when exports increased by X% against the previous year. Over the period under review, the exports hit record highs in 2021 and are likely to see steady growth in the immediate term.

In value terms, human and animal blood exports soared to $X in 2021. In general, exports showed a significant increase. The most prominent rate of growth was recorded in 2020 with an increase of X% against the previous year. Over the period under review, the exports reached the maximum in 2021 and are likely to see steady growth in the near future.

Exports by Country

India prevails in exports structure, amounting to X tons, which was near X% of total exports in 2021. Pakistan (X tons) followed a long way behind the leaders.

From 2012 to 2021, average annual rates of growth with regard to human and animal blood exports from India stood at +X%. At the same time, Pakistan (+X%) displayed positive paces of growth. Moreover, Pakistan emerged as the fastest-growing exporter exported in Southern Asia, with a CAGR of +X% from 2012-2021. Pakistan (+X p.p.) significantly strengthened its position in terms of the total exports, while India saw its share reduced by -X% from 2012 to 2021, respectively.

In value terms, India ($X) remains the largest human and animal blood supplier in Southern Asia, comprising X% of total exports. The second position in the ranking was held by Pakistan ($X), with a X% share of total exports.

In India, human and animal blood exports expanded at an average annual rate of +X% over the period from 2012-2021.

Export Prices by Country

In 2021, the export price in Southern Asia amounted to $X per ton, dropping by -X% against the previous year. Overall, the export price showed a abrupt setback. The pace of growth appeared the most rapid in 2019 an increase of X%. The level of export peaked at $X per ton in 2012; however, from 2013 to 2021, the export prices failed to regain momentum.

Prices varied noticeably by the country of origin: the country with the highest price was India ($X per ton), while Pakistan amounted to $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by India (-X%).

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in Southern Asia

In 2021, approx. X tons of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were imported in Southern Asia; surging by X% against 2020. Overall, imports saw a buoyant increase. The pace of growth was the most pronounced in 2016 when imports increased by X% against the previous year. The volume of import peaked in 2021 and is expected to retain growth in the immediate term.

In value terms, human and animal blood imports surged to $X in 2021. Over the period under review, imports posted a resilient expansion. As a result, imports attained the peak and are likely to continue growth in the immediate term.

Imports by Country

In 2021, India (X tons) was the key importer of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, creating X% of total imports. Pakistan (X tons) ranks second in terms of the total imports with a X% share, followed by Sri Lanka (X%) and Bangladesh (X%).

From 2012 to 2021, average annual rates of growth with regard to human and animal blood imports into India stood at +X%. At the same time, Sri Lanka (+X%), Bangladesh (+X%) and Pakistan (+X%) displayed positive paces of growth. Moreover, Sri Lanka emerged as the fastest-growing importer imported in Southern Asia, with a CAGR of +X% from 2012-2021. From 2012 to 2021, the share of Sri Lanka and Bangladesh increased by +X and +X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, India ($X) constitutes the largest market for imported human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Southern Asia, comprising X% of total imports. The second position in the ranking was taken by Pakistan ($X), with a X% share of total imports. It was followed by Sri Lanka, with a X% share.

From 2012 to 2021, the average annual growth rate of value in India stood at +X%. In the other countries, the average annual rates were as follows: Pakistan (+X% per year) and Sri Lanka (+X% per year).

Import Prices by Country

The import price in Southern Asia stood at $X per ton in 2021, growing by X% against the previous year. Over the period from 2012 to 2021, it increased at an average annual rate of +X%. As a result, import price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was India ($X per ton), while Bangladesh ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by India (+X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :